Table 1.
Baseline demographic and clinical characteristics of psoriasis and control groups.
| Psoriasis group n=33 |
Control group n=26 |
p Value | |
|---|---|---|---|
| Male gender | 22 | 15 | NS* |
| Age (years) | 41±11 | 39±11 | NS* |
| BMI (kg/m2) | 28.2±4.6 | 26.8±3.0 | NS* |
| Total cholesterol (mg/dl) | 206.8±38.5 | 169.7±34.5 | .001 |
| HDL-C (mg/dl) | 42.1±10.2 | 54.0±14.7 | .001 |
| LDL-C (mg/dl) | 121.1±26.1 | 95.1±33.9 | .004 |
| Triglycerides (mg/dl) | 219.7±170.5 | 102.1±67.2 | .004 |
| Hb (g/dl) | 14.5±1.8 | 13.9±1.7 | NS* |
| Systolic BP (mmHg) | 131±16 | 124±16 | NS* |
| Diastolic BP (mmHg) | 73±10 | 79±8 | .016 |
| Resting Pulse (beat/minute) | 78±9 | 76±12 | NS* |
| LVEDD (mm) | 45±4 | 45±3 | NS* |
| LVESD (mm) | 29±4 | 29±5 | NS* |
| LVEF (%) | 63±3 | 63±3 | NS* |
*
Not significant.